Showing results (91-100 of 238) with videos related to

Sort By:
Pageof 24
British Journal of Haematology|April 1, 2015
Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapyChezi Ganzel, Sean Devlin, Dan Douer, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 4, 2016
Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic CriteriaCatherine C Coombs, Lisa M DeAngelis, James H Feusner, et al.
Haematologica|November 4, 2005
Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptorYona Nadir, Tamar Katz, Galit Sarig, et al.
Acta Haematologica|December 20, 2011
The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experienceEmilia Hardak, Ilana Oren, Eldad J Dann, et al.
Human Reproduction (Oxford, England)|April 9, 2005
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphomaEldad J Dann, Ron Epelbaum, Irit Avivi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trialDror Mevorach, Tsila Zuckerman, Inna Reiner, et al.
American Journal of Hematology|February 21, 2013
Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab eraIrit Avivi, Ariel Zilberlicht, Eldad J Dann, et al.
Hematological Oncology|January 14, 2012
Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVECMaya Koren-Michowitz, Yulia Volchek, Elizabeth Naparstek, et al.
British Journal of Haematology|January 25, 2003
Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapyMartine Szyper-Kravitz, Orit Uziel, Hava Shapiro, et al.
Haematologica|May 7, 2011
Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remissionMarc Buyse, Stefan Michiels, Pierre Squifflet, et al.
Pageof 24